Compare AstraZeneca plc (AZN) vs Cintas Corporation (CTAS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Cintas Corporation — how do they compare? AstraZeneca plc trades at $165.31 (market cap $258.17B), while Cintas Corporation trades at $185.3 (market cap $73.53B). The key difference: AstraZeneca plc is far larger — about 3.5× Cintas Corporation's market cap, and AstraZeneca plc pays the higher dividend (1.87%). Which is the better fit depends on your goals.
| AZN | CTAS | |
|---|---|---|
Market Cap | $258.17B | $73.53B |
Sector | Health | Industrials |
52-Week High | $209.48 | $226.27 |
52-Week Low | $137.44 | $163.55 |
Enterprise Value | $284.41B | $76.26B |
Dividend Yield | 1.87% | 0.98% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Cintas Corporation
In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).
Read more on CTAS →
